Pathfinder Cell Therapy Overview

Pathfinder Cell Therapy EBIT

EBIT (Earnings Before Interest and Taxes) analysis for PFND.

Quarterly EBIT

-$209.00K

↑ 1.88% YoY

As of Sep 30, 2015

Annual EBIT (TTM)

-$775.00K

↑ 40.79% YoY

Trailing 12 months ending Sep 30, 2015

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin